KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 153 filers reported holding KURA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2023 | $2,592 | -81.6% | 245 | -78.7% | 0.00% | -100.0% |
| Q1 2023 | $14,065 | +160.6% | 1,150 | +164.4% | 0.00% | +100.0% |
| Q4 2022 | $5,398 | -40.0% | 435 | -34.5% | 0.00% | -50.0% |
| Q3 2022 | $9,000 | -35.7% | 664 | -10.3% | 0.00% | 0.0% |
| Q2 2022 | $14,000 | +7.7% | 740 | -7.4% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -50.0% | 799 | -57.5% | 0.00% | -50.0% |
| Q4 2021 | $26,000 | +1200.0% | 1,878 | +1655.1% | 0.00% | +300.0% |
| Q3 2021 | $2,000 | 0.0% | 107 | 0.0% | 0.00% | – |
| Q2 2021 | $2,000 | -33.3% | 107 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $3,000 | 0.0% | 107 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $3,000 | 0.0% | 107 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | +50.0% | 107 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $2,000 | +100.0% | 107 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 107 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,807,982 | $59,049,000 | 6.41% |
| ACUTA CAPITAL PARTNERS, LLC | 637,500 | $20,821,000 | 5.67% |
| Asymmetry Capital Management, L.P. | 346,518 | $11,317,000 | 5.16% |
| Affinity Asset Advisors, LLC | 260,000 | $8,492,000 | 4.50% |
| EcoR1 Capital, LLC | 1,773,037 | $57,907,000 | 3.11% |
| VR Adviser, LLC | 575,000 | $18,780,000 | 2.76% |
| COMMODORE CAPITAL LP | 133,503 | $4,360,000 | 2.37% |
| Ghost Tree Capital, LLC | 325,000 | $10,615,000 | 2.36% |
| Avoro Capital Advisors LLC | 4,000,000 | $130,640,000 | 2.25% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 90,000 | $2,939,000 | 1.71% |